Prognostic significance of fibroblast growth factor 19 (FGF19) expression in breast invasive ductal carcinoma (original) (raw)

High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast

Jaudah Al-maghrabi, Muhammad Abu-Elmagd

Tumor Biology, 2014

View PDFchevron_right

Fibroblast Growth Factor 19 is an Independent Prognostic Parameter for Hepatocellular Carcinoma Recurrence

Dina Sweed

International Journal of Cancer and Biomedical Research

View PDFchevron_right

Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast

清 向井

Cancer Science, 2010

View PDFchevron_right

Biological Staging of Incipient, in Situ, and Invasive Breast Carcinomas

Patrizia Querzoli

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

Ductal carcinoma in situ of the breast—current management

Niall OHiggins

European Journal of Surgical Oncology (EJSO), 1997

View PDFchevron_right

Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer

Graham Colditz

Cancer Research, 2012

View PDFchevron_right

Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma

Fred C. G. J. Sweep

Cancer, 2004

View PDFchevron_right

Management of breast fibroadenomas

Y. Skornick

Journal of General Internal Medicine, 1998

View PDFchevron_right

Immunohistochemical expression of epidermal growth factor receptor in benign and malignant lesions of the breast

A. Colige

Acta Histochemica et Cytochemica, 1991

View PDFchevron_right

Targeting Nuclear FGF Receptor to Improve Chemotherapy Response in Triple-Negative Breast Cancer

Robin Bachelder

2014

View PDFchevron_right

Stromal Signatures of Breast Carcinogenesis in Fibroadenoma—A Pilot Study

Rani Kanthan

Journal of carcinogenesis & mutagenesis, 2011

View PDFchevron_right

Influence of tumor biological factors on tumor cell dissemination in primary breast cancer

Bernhard Kraemer

Anticancer research

View PDFchevron_right

An Assessment of Angiogenesis in Fibrocystic Breast Disease and Invasive Breast Carcinoma

Dr.Dhanalakshmi Arumugam

Journal of Evolution of Medical and Dental Sciences, 2017

View PDFchevron_right

Chances of breast cancer with fibroadenoma- Review

Rihana Begum P

Journal of scientific and innovative research, 2017

View PDFchevron_right

Responsiveness to Transforming Growth Factor-β (TGF-β)-Mediated Growth Inhibition Is a Function of Membrane-Bound TGF-β Type II Receptor in Human Breast Cancer Cells

Danica Ramljak

Gene Expression, 2001

View PDFchevron_right

Expression of basic fibroblastic growth factor (bFGF) in invasive ductal carcinoma of breast and its relation to angiogenesis and other prognostic parameters

Tahsin Colak

2005

View PDFchevron_right

Effect of Primary Tumour Resection on Patients Survival in Stage IV Breast Cancer

gurkan dumlu

British Journal of Medicine and Medical Research, 2013

View PDFchevron_right

Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index

Jose Jerez

Breast Cancer Research, 2013

View PDFchevron_right

Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness

Assia Bassarova

2012

View PDFchevron_right

Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling

Murielle Veniant

Journal of Biological Chemistry, 2007

View PDFchevron_right

Revisiting the IGF-1R as a breast cancer target

Chiminch Boeky

npj Precision Oncology, 2017

View PDFchevron_right

Clinical and molecular aspects of breast cancer: Targets and therapies

Glauber Leitao

Biomedicine & Pharmacotherapy, 2018

View PDFchevron_right

The role of the insulin-like growth factor-1 system in breast cancer

Michael Koutsilieris

Molecular Cancer, 2015

View PDFchevron_right

A Clinical Study of Locally Advanced Carcinoma of Breast

junaid ahmad Sheikh

Journal of Evidence Based Medicine and Healthcare, 2015

View PDFchevron_right

Role of FNAC in extramammary tumors metastatic to the breast

Kanwalpreet Kaur

Journal of Cytology, 2020

View PDFchevron_right

Prognostic value of immunohistochemical stratification of invasive duct carcinoma of the breast

Asmaa Salama

The Chinese-German Journal of Clinical Oncology, 2013

View PDFchevron_right

Surgical and Local-regional Treatment of “Early” Invasive Breast Cancer

David Hetzel

Clinical Obstetrics and Gynecology, 2011

View PDFchevron_right

Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome

Tianjie Pu

Oncology Letters

View PDFchevron_right

Connective tissue growth factor in tumor pathogenesis

Annica Rasmusson

Fibrogenesis & Tissue Repair, 2012

View PDFchevron_right

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma

Ramon Colomer

1997

View PDFchevron_right

Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21

Kumar Ganesan

Research Square (Research Square), 2023

View PDFchevron_right

Inhibition of ductal morphogenesis in the mammary gland of WAP-fgf4 transgenic mice

Patrizia Damonte

Anatomy and embryology, 2003

View PDFchevron_right

Systemic treatment of early breast cancer-a biological perspective

Sally Greenberg

Journal of Surgical Oncology, 2011

View PDFchevron_right

EGFR-Ligand Signaling in Breast Cancer Metastasis: Recurring Developmental Themes

David Riese

Breast Cancer - Carcinogenesis, Cell Growth and Signalling Pathways, 2011

View PDFchevron_right

Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study

alberto bonetta

Radiation Oncology, 2012

View PDFchevron_right